Press Releases

Media Contact: Michelle Kirkwood, 703-299-2053 or mkirkwood@diabetes.org.

The most recent press releases from the American Diabetes Association:

June 14, 2016
Pioglitazone Decreases Type 2 Diabetes Risk in Stroke Patients with Insulin Resistance
Pioglitazone greatly decreases the risk of developing type 2 diabetes, especially for those who already have prediabetes and/or who have had strokes, according to a study presented at the American Diabetes Association's 76th Scientific Sessions® at the Ernest N. Morial Convention Center in New Orleans.

June 14, 2016
Bionic Pancreas Reduces Hypoglycemia with Automated Glucagon Delivery
Delivering small doses of glucagon through an automated continuous glucose monitoring system can substantially reduce hypoglycemia (low blood glucose levels) in patients with type 1 diabetes, especially at night, according to a study presented at the American Diabetes Association's 76th Scientific Sessions at the Ernest N. Morial Convention Center in New Orleans.

June 14, 2016
New Diabetes Prevention Program Data Indicates Physical Activity Helps Prevent Type 2 Diabetes, Independent of Weight Loss
Physical activity, independent of weight loss, may help to prevent or delay type 2 diabetes in people who are at high risk for diabetes, according to new follow-up data from the landmark Diabetes Prevention Program (DPP) study, presented today in the President’s Oral Session at the American Diabetes Association's 76th Scientific Sessions at the Ernest N. Morial Convention Center in New Orleans.

June 13, 2016
Liraglutide Lowers Risk for Cardiovascular Complications, Kidney Disease and Death in People with Type 2 Diabetes
Liraglutide, a glucose-lowering drug, has been shown to safely and effectively lower the overall risk of heart attack, stroke or cardiovascular death among people with type 2 diabetes at high risk for cardiovascular disease, according to results from the Liraglutide Effect and Action in Diabetes – Evaluation of Cardiovascular Outcome Results (LEADER) trial.

June 13, 2016
Recipients of Prestigious "Pathway to Stop Diabetes" Grants Will Highlight Their Research Progress at the 76th Scientific Sessions
Distinguished grant recipients of the American Diabetes Association's "Pathway to Stop Diabetes" research initiative will present the latest progress in their respective research grants during the Association's 76th Scientific Sessions, June 10-14, 2016, at the Ernest N. Morial Convention Center in New Orleans.

June 12, 2016
Lifestyle Intervention Achieves Increased Reduction in A1C After Six Months for African Americans with Type 2 Diabetes
A study designed to test the impact of an intensive lifestyle intervention program on lowering blood glucose levels in low-income, African Americans with type 2 diabetes successfully reduced A1C after six months, relative to standard-of-care diabetes education.

June 12, 2016
American Diabetes Association and IBM Watson Health Join Forces to Reimagine How Diabetes is Prevented and Managed
The American Diabetes Association and IBM Watson Health today announced a long-term collaboration to bring together the cognitive computing power of Watson and the Association's vast repository of clinical and research data. The organizations aim to build a first-of-its-kind diabetes advisor for patients and caregivers.

June 11, 2016
Beyond A1C—Why Quality of Life Matters
Health-related quality of life (HRQOL) is an important area of investigation that has gained increasing recognition and is a critical element of diabetes research, treatment and care, according to experts at the Symposium, "Beyond A1C—Why Quality of Life Matters," presented on June 11, 2016, during the American Diabetes Association's 76th Scientific Sessions, June 10-14, 2016, at the Ernest N. Morial Convention Center in New Orleans.

June 11, 2016
Secondary Analysis of EXAMINE Trial Finds Highest Risk of Cardiovascular Death for Patients Previously Hospitalized with Heart Failure
People with type 2 diabetes and heart disease who experience non-fatal cardiovascular events are at increased risk of cardiovascular-related death, and those previously hospitalized for heart failure are at highest risk, according to new analysis of data from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) trial.

June 11, 2016
Home Use of a Dual Hormone, Bionic Pancreas Safely Reduces Blood Glucose Levels and Hypoglycemia in Adults While Continuing Normal Daily Activities
Use of a biohormonal, bionic pancreas in the home setting can safely and effectively lower mean blood glucose levels and hypoglycemia (low blood glucose), compared to the use of an insulin pump, in adults with type 1 diabetes performing normal daily activities, according to a study presented at the Association’s 76th Scientific Sessions, June 11, 2016, at the Ernest N. Morial Convention Center in New Orleans.

June 11, 2016
Use of an Insulin-Only Bionic Pancreas Effectively Controls Blood Glucose Levels
Use of an insulin-only bionic pancreas effectively controls blood glucose levels, with no difference in episodes of hypoglycemia (low blood glucose levels), compared to a bihormonal (insulin plus glucagon) bionic pancreas, when both insulin-only and bihormonal configurations used a target blood sugar of 130 mg/dl, according to a study presented at the American Diabetes Association's 76th Scientific Sessions at the Ernest N. Morial Convention Center in New Orleans.

June 10, 2016
American Diabetes Association Acquires Intelligent Medical Decisions, Inc.
The American Diabetes Association today announced the acquisition of Intelligent Medical Decisions, Inc.. The Association and iMD have collaborated for the past five years to design and deliver Diabetes INSIDE—a quality improvement initiative that has improved diabetes care processes and health outcomes for people living with diabetes at large, diverse health systems across the country.

June 10, 2016
Innovative Approaches to Treating Type 1 Diabetes Addressed in Beta-Cell Replacement Presentations
Transplanting islet cells from pigs into humans and developing "universal donor" stem cell lines are two innovative approaches being explored for replacing deteriorating beta cells in people with type 1 diabetes, investigators explained during a news briefing and symposium on June 10, 2016, at the American Diabetes Association's 76th Scientific Sessions at the Ernest N. Morial Convention Center in New Orleans.

June 8, 2016
Shashank S. Shah, MBBS, MS, to Receive American Diabetes Association's 2016 Vivian Fonseca Scholar Award
Shashank S. Shah, MBBS, MS, FAIS, FICS (Hon), FMAS (Hon), FIAGES (Hon), FALS (Hon), DLS (France), will receive the American Diabetes Association's 2016 Vivian Fonseca Scholar Award, given in memory of Mr. P. Nagendran. The Vivian Fonseca Scholar Award recognizes diabetes research focused on the South Asian, Asian American, Native Hawaiian and Pacific Islander populations and/or research by a scientist from these areas.

June 7, 2016
Clay F. Semenkovich, MD, Receives the American Diabetes Association's 2016 Edwin Bierman Award
Clay F. Semenkovich, MD, has been selected to receive the American Diabetes Association's 2016 Edwin Bierman Award. This award recognizes a leading scientist who has made outstanding contributions in the field of diabetes-related macrovascular complications and related risk factors.

June 6, 2016
H. David McIntyre, MD, FRACP, Receives American Diabetes Association's 2016 Norbert Freinkel Award
H. David McIntyre, MD, FRACP, has been selected to receive the American Diabetes Association's 2016 Norbert Freinkel Award, given in memory of Norbert Freinkel, a dedicated and insightful investigator and a gifted writer. The Norbert Freinkel Award honors a researcher who has made outstanding contributions, including scientific publications and presentations, to the understanding and treatment of diabetes in pregnancy.

June 3, 2016
Nicolaas C. Schaper, MD, PhD, Receives American Diabetes Association's 2016 Roger Pecoraro Award
Nicolaas C. Schaper, MD, PhD, has been selected to receive the American Diabetes Association's 2016 Roger Pecoraro Award. This award recognizes a researcher who has made scientific contributions and demonstrates an untiring commitment to improving the understanding of the detection, treatment and prevention of diabetic foot complications.

June 2, 2016
Elizabeth Arquin Walker, PhD, RN, Named American Diabetes Association's 2016 Richard R. Rubin Award Recipient
Elizabeth Arquin Walker, PhD, RN, has been selected to receive the American Diabetes Association’s 2016 Richard R. Rubin Award. This award recognizes a behavioral researcher who has made outstanding, innovative contributions to the study and understanding of the behavioral aspects of diabetes in diverse populations.

May 31, 2016
Edward W. Gregg, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology
Edward W. Gregg, PhD, is the recipient of the American Diabetes Association’s 2016 Kelly West Award for Outstanding Achievement in Epidemiology. This award recognizes significant contributions to the field of diabetes epidemiology.

May 27, 2016
Yutaka Seino, MD, PhD, Receives American Diabetes Association's 2016 Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes
Yutaka Seino, MD, PhD, has been selected to receive the American Diabetes Association’s 2016 Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes. This award honors individual outstanding service in the cause of diabetes, performed with an international perspective and with international impact.

  • Last Reviewed: November 18, 2013
  • Last Edited: April 1, 2016